Kinase Inhibitors in the Treatment of Thyroid Cancer: Institutional Experience

Although most patients with thyroid cancer have a favorable clinical course, some patients develop a more aggressive type of cancer and exhibit more rapid disease progression with worse prognosis. Those patients usually exhibit mutations of proteins such as tyrosine kinase enzymes that play a signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Pešorda, Matea, Kusačić Kuna, Sanja, Huić, Dražen, Herceg, Davorin, Despot, Marija, Samardžić, Tatjana, Gnjidić, Milena, Belev, Borislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212607/
https://www.ncbi.nlm.nih.gov/pubmed/34219887
http://dx.doi.org/10.20471/acc.2020.59.s1.09

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212607/
https://www.ncbi.nlm.nih.gov/pubmed/34219887
http://dx.doi.org/10.20471/acc.2020.59.s1.09

Ejemplares similares